Fairvalue-Calculator Fairvalue-Calculator
EN DE

Camp4 Therapeutics Corporation (CAMP) Fair Value & Analysis

Healthcare · US · Market cap $214M

Price$4.36
Fair Value$4.13
Upside-5.3%
Quality95/100
Evidence: Low Range $3.10 – $5.17

Fair value as of: Jun 24, 2026

Analysis

Camp4 Therapeutics Corporation (CAMP) currently trades at $4.36, while our model-based Fair Value estimate is $4.13 — implying the stock looks roughly 5.3% overvalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Camp4 Therapeutics Corporation, a clinical-stage biopharmaceutical company, discovers and develops RNA-based therapeutics to treat a range of genetic diseases. Its lead product candidate is CMP-001, which is in a Phase 1/2 clinical trial for the treatment of urea cycle disorders. The company also develops CMP-002 for the treatment of SYNGAP1-related disorders. Camp4 Therapeutics Corporation was formerly known as Marauder Therapeutics, Inc. and changed its name to Camp4 Therapeutics Corporation in March 2018. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Open the full interactive analysis →

Similar stocks

Vertex Pharmaceuticals Incorporated (VRTX34) -38% Regeneron Pharmaceuticals, Inc (REGN) -14% UCB SA (UCB) -28% argenx SE (ARGNF) -57% Samsung Biologics Co (207940) -28% Alnylam Pharmaceuticals, Inc (ALNY) -63%

Frequently asked questions

Is Camp4 Therapeutics Corporation (CAMP) undervalued?
As of Jun 24, 2026, our model estimates a fair value of $4.13 versus a price of $4.36 — about −5% (overvalued). Model-based estimate, not financial advice.
What is the fair value of CAMP?
Our 21-model fair value for Camp4 Therapeutics Corporation is $4.13 (as of Jun 24, 2026), built from audited fundamentals. The current price is $4.36.
What is the quality score of CAMP?
Camp4 Therapeutics Corporation has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.